stockrow
Friday 6 November 2026
Export ACH’s income statement to Excel — free account
Accendra Health, Inc.
ACH Healthcare Medical Distribution
Accendra Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.8 billion, up 3.06% from fiscal 2024.
- Revenue
- −10.1%
- EPS
- +89.7%
- Free cash flow
- −1,624.8%
- Total debt
- −13.1%
Quarter to June 2026, against a year earlier
0.21
0.09
−30.00%
Follow ACH
Alert me
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
20.51 | 16.01 | 0.00 | 0.00 | 69.36 | 14.26 | 63.23 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
7 | 4 | 3 | 5 | 6 | 7 | 4 | 4 | 4 | 2 |
P/S ratio |
0.23 | 0.12 | 0.04 | 0.03 | 0.20 | 0.32 | 0.15 | 0.14 | 0.37 | 0.08 |
Altman Z-Score |
5.32 | 3.73 | 2.67 | 3.03 | 3.49 | 4.33 | 2.40 | 0.95 | 0.62 | 0.40 |
P/FCF ratio |
13.61 | 173.47 | 7.36 | 2.75 | 6.12 | 42.48 | 7.06 | 2.30 | 20.57 | 0.00 |
Altman Z″-Score (non-manufacturers) |
4.13 | 2.99 | 1.57 | 2.20 | 2.41 | 3.25 | 1.54 | 0.92 | 0.09 | (2.59) |
Beneish M-Score |
(2.58) | (2.12) | (3.28) | (2.70) | (2.82) | (2.34) | (2.53) | (2.49) | (3.61) | (2.92) |
P/Operating CF |
51.35 | 22.73 | (54.90) | 11.61 | 24.13 | 62.86 | 16.79 | 13.05 | 14.13 | 3.16 |
P/B ratio |
2.31 | 1.14 | 0.73 | 0.68 | 2.41 | 3.37 | 1.54 | 1.58 | 1.71 | 0.00 |
Price to Tangible BV |
4.79 | 9.92 | 0.00 | 0.00 | 22.97 | 9.35 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.29 | 0.23 | 0.23 | 0.19 | 0.31 | 0.42 | 0.39 | 0.32 | 1.05 | 0.72 |
EV/EBITDA |
10.98 | 14.53 | 11.44 | 9.42 | 8.91 | 8.93 | 10.47 | 9.64 | 10.41 | 8.20 |
EV/Operating CF |
14.91 | 38.06 | 18.72 | 10.76 | 7.82 | 33.02 | 11.97 | 4.47 | 17.44 | (19.48) |
EV/FCF |
17.18 | 322.51 | 41.94 | 15.70 | 9.47 | 55.05 | 18.82 | 5.23 | 57.77 | (8.81) |
Quick Ratio |
0.77 | 0.66 | 0.56 | 0.52 | 0.58 | 0.55 | 0.53 | 0.44 | 0.13 | 0.40 |
Current Ratio |
1.90 | 1.67 | 1.72 | 1.70 | 1.59 | 1.73 | 1.47 | 1.11 | 1.09 | 0.58 |
Net Debt/EBITDA |
1.49 | 5.35 | 8.36 | 7.77 | 3.15 | 2.04 | 6.54 | 5.40 | 6.70 | 7.31 |
Debt/Assets |
20.77% | 26.68% | 43.67% | 42.31% | 30.58% | 28.04% | 46.43% | 41.18% | 39.54% | 83.61% |
Debt/Equity |
0.59 | 0.89 | 3.18 | 3.34 | 1.43 | 1.06 | 2.64 | 2.27 | 3.14 | (4.45) |
Asset Turnover |
3.54 | 3.06 | 2.63 | 2.48 | 2.43 | 2.85 | 2.23 | 0.49 | 0.55 | 0.78 |
Operating CF/Net income |
1.74 | 0.79 | (0.26) | (2.66) | 11.36 | 0.56 | 14.52 | (17.93) | (0.45) | 0.09 |
Capex/Depreciation |
(0.45) | (0.84) | (0.12) | (0.45) | (0.63) | (0.55) | (0.52) | (0.51) | (0.23) | (0.57) |
Interest Coverage |
7.38 | 2.81 | (4.96) | 0.75 | 2.45 | 7.66 | 1.11 | 1.14 | (2.02) | 0.26 |
| 11.03% | 7.26% | (56.98%) | (12.72%) | 5.09% | 26.85% | 2.38% | (4.42%) | (48.02%) | (1,755.61%) | |
| 3.92% | 2.35% | (12.22%) | (1.68%) | 0.86% | 6.45% | 0.50% | (0.79%) | (7.44%) | (30.97%) | |
ROIC |
9.32% | 3.08% | (10.49%) | 2.36% | 7.74% | 12.29% | 2.64% | 3.00% | (5.67%) | 1.31% |
Return on Tangible Assets |
9.62% | 6.65% | (31.43%) | (4.77%) | 2.70% | 17.11% | 1.71% | (5.47%) | (86.72%) | 769.45% |
Average Days of Receivables |
22.75 | 29.73 | 29.33 | 26.74 | 30.16 | 25.42 | 27.99 | 85.55 | 29.73 | 12.67 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
9.98% | 10.91% | 10.12% | 11.11% | 12.28% | 11.01% | 15.62% | 39.24% | 40.38% | 38.65% |
Intangible Assets out of Total Assets |
0.18 | 0.27 | 0.19 | 0.19 | 0.19 | 0.17 | 0.39 | 0.39 | 0.31 | 0.56 |
Share Based Compensation of Revenue |
0.12% | 0.13% | 0.17% | 0.17% | 0.24% | 0.26% | 0.21% | 0.56% | 0.62% | 0.47% |
Graham Net Nets |
0.09 | (0.15) | (1.89) | (2.47) | (0.28) | (0.09) | (1.47) | (1.42) | (2.04) | (10.98) |
Graham Number |
25.02 | 21.47 | 0.00 | 0.00 | 9.93 | 29.76 | 9.41 | 0.00 | 0.00 | 43.90 |
Earnings Yield |
4.88% | 6.25% | (115.64%) | (20.12%) | 1.44% | 7.01% | 1.58% | (2.81%) | (36.11%) | (510.36%) |
Free Cash Flow Yield |
7.35% | 0.58% | 13.58% | 36.36% | 16.34% | 2.35% | 14.16% | 43.44% | 4.86% | (104.57%) |
Revenue per Share |
159.16 | 155.30 | 156.93 | 152.06 | 133.82 | 134.52 | 133.64 | 33.68 | 34.92 | 35.92 |
Operating CF per Share |
3.07 | 0.95 | 1.93 | 2.74 | 5.35 | 1.71 | 4.36 | 9.77 | 2.10 | (1.32) |
Capex per Share |
(0.41) | (0.83) | (1.07) | (0.86) | (0.93) | (0.68) | (1.59) | (1.41) | (1.47) | (1.60) |
Free Cash Flow per Share |
2.67 | 0.11 | 0.86 | 1.88 | 4.42 | 1.02 | 2.78 | 8.36 | 0.64 | (2.93) |
Cash per Share |
3.04 | 1.74 | 1.10 | 1.11 | 1.31 | 0.77 | 0.93 | 3.21 | 0.36 | 3.67 |
Shareholders Equity per Share |
15.71 | 16.92 | 8.64 | 7.63 | 11.24 | 12.90 | 12.69 | 12.19 | 7.64 | (5.99) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
15.71 | 16.92 | 8.64 | 7.63 | 11.24 | 12.90 | 12.69 | 12.19 | 7.64 | (5.99) |
Free Cash Flow |
162.95 | 6.70 | 51.59 | 113.86 | 280.03 | 74.49 | 206.81 | 633.75 | 48.76 | (225.15) |
Working Capital |
927.40 | 872.17 | 1,066.57 | 991.12 | 790.14 | 977.79 | 728.72 | 210.91 | 168.97 | (399.20) |
Capital Expenditures |
(24.75) | (50.07) | (63.99) | (52.23) | (59.19) | (49.69) | (118.20) | (106.96) | (112.74) | (123.36) |
Net Current Asset Value |
204.33 | (178.91) | (716.79) | (773.65) | (487.72) | (276.24) | (2,145.49) | (2,066.37) | (2,048.77) | (2,364.87) |
EV/EBIT |
14.02 | 24.21 | 0.00 | 24.44 | 12.99 | 11.13 | 27.23 | 24.87 | 0.00 | 72.22 |
Capex to Sales |
0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.04 | 0.04 | 0.04 |
Price to Operating Income |
11.11 | 13.02 | 0.00 | 4.28 | 8.40 | 8.59 | 10.22 | 10.95 | 0.00 | 7.84 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.29 | 0.29 | 1.67 | 0.37 | 0.30 | 0.29 | 0.40 | 0.39 | 1.96 | 0.84 |
Cash ROIC |
9.53% | 0.33% | 2.31% | 5.50% | 15.43% | 3.75% | 5.88% | 19.41% | 1.99% | (12.03%) |
Accounts Receivable Turnover |
16.29 | 13.65 | 12.43 | 12.87 | 12.33 | 14.16 | 13.78 | 3.75 | 6.56 | 17.58 |
Accounts Payable Turnover |
11.68 | 9.59 | 8.29 | 8.63 | 7.96 | 8.26 | 7.56 | 1.15 | 1.83 | 4.07 |
Inventory Turnover |
9.19 | 8.55 | 7.37 | 6.68 | 6.05 | 6.06 | 5.75 | 1.09 | 2.38 | 20.74 |
Average Days of Payables |
32.10 | 42.46 | 46.58 | 36.49 | 50.71 | 44.21 | 51.52 | 320.27 | 93.86 | 90.11 |
Days of Inventory on Hand |
39.18 | 44.37 | 55.69 | 51.76 | 62.55 | 66.01 | 59.88 | 303.52 | 17.62 | 18.45 |
Average Receivables |
597.01 | 682.51 | 757.81 | 715.70 | 687.75 | 691.18 | 722.53 | 680.88 | 408.26 | 157.09 |
Average Payables |
730.68 | 849.16 | 1,006.38 | 936.62 | 904.11 | 1,001.07 | 1,074.69 | 1,159.65 | 765.90 | 361.75 |
Average Inventory |
928.54 | 953.25 | 1,131.96 | 1,209.96 | 1,189.97 | 1,364.86 | 1,414.78 | 1,222.10 | 589.09 | 71.01 |
Average Assets |
2,745.76 | 3,047.02 | 3,575.04 | 3,708.44 | 3,489.36 | 3,436.10 | 4,461.42 | 5,239.80 | 4,874.74 | 3,553.96 |
Average Common Equity |
976.31 | 987.76 | 766.95 | 490.29 | 587.10 | 825.28 | 942.05 | 934.89 | 755.27 | 62.69 |
Columns are period end dates · fundamentals updated 26 Oct 2026